Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Discovery: Overview01:26

Drug Discovery: Overview

10.8K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.8K
Dosage Regimens: Partial Pharmacokinetic Parameters01:01

Dosage Regimens: Partial Pharmacokinetic Parameters

108
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
108
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

208
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
208
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

6.6K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
6.6K
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

621
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
621
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry01:20

Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry

450
Orally administered drugs primarily enter the systemic circulation via passive diffusion through the intestinal membranes. The drug's absorption is influenced by drug stability in the gastrointestinal GI tract, membrane permeability, the surface area available for absorption, luminal drug concentration, and residence time in the lumen. Drug permeability can be enhanced by adjusting the lipophilicity, polarity, or molecular size of the drug, promoting its passive transport across intestinal...
450

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Efficacy of recombinant human collagen serum for improving skin dryness and roughness in striae gravidarum: a clinical study.

African journal of reproductive health·2026
Same author

Patient-centered communication in cosmetic eyelid surgery consultations in China: an observational transcript-based E5 study.

BMC health services research·2026
Same author

ProMeta: a meta-learning framework for robust disease diagnosis and prediction from plasma proteomics.

Bioinformatics (Oxford, England)·2026
Same author

Towards the construction of a virtual yeast.

Nature·2026
Same author

Deep learning reveals antimicrobial peptides within prions.

Nature microbiology·2026
Same author

A generative artificial intelligence approach for peptide antibiotic optimization.

Nature machine intelligence·2026

Related Experiment Video

Updated: Dec 30, 2025

Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

19.4K

Secure multiparty computation for privacy-preserving drug discovery.

Rong Ma1, Yi Li1, Chenxing Li1

  • 1Institute for Interdisciplinary Information Sciences, Tsinghua University, Beijing 100084, China.

Bioinformatics (Oxford, England)
|January 18, 2020
PubMed
Summary

Pharmaceutical institutions can now collaborate on quantitative structure-activity relationship (QSAR) and drug-target interaction (DTI) prediction using secure multiparty computation (MPC). Novel algorithms QSARMPC and DTIMPC enable privacy-preserving drug discovery advancements.

More Related Videos

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
07:51

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

Published on: May 21, 2018

12.4K
Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
08:49

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

1.0K

Related Experiment Videos

Last Updated: Dec 30, 2025

Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

19.4K
High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
07:51

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

Published on: May 21, 2018

12.4K
Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
08:49

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

1.0K

Area of Science:

  • Computational chemistry
  • Bioinformatics
  • Drug discovery

Background:

  • Quantitative structure-activity relationship (QSAR) and drug-target interaction (DTI) prediction are crucial in drug discovery.
  • Inter-institutional collaboration can enhance QSAR and DTI prediction performance.
  • Data privacy and intellectual property concerns hinder collaboration in drug discovery.

Purpose of the Study:

  • To develop novel algorithms for privacy-preserving collaborative drug discovery.
  • To enable high-quality collaboration without divulging sensitive drug-related information.

Main Methods:

  • Developed two algorithms, QSARMPC and DTIMPC, utilizing secure multiparty computation (MPC).
  • QSARMPC is a neural network model for scalable, privacy-preserving QSAR prediction.
  • DTIMPC integrates heterogeneous network data for confidential DTI prediction.

Main Results:

  • QSARMPC demonstrates good scalability and performance for large-scale QSAR prediction.
  • DTIMPC shows significant performance improvement over baselines and predicts novel DTIs with literature support.
  • Both algorithms exhibit feasible scalability for growing drug discovery data.

Conclusions:

  • QSARMPC and DTIMPC offer practical solutions for privacy-preserving collaborative drug discovery.
  • These tools facilitate advancements in drug discovery by overcoming data privacy barriers.